The Acute Kidney Injury Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market for acute kidney injury has experienced significant growth in recent years. The market size was $5.37 billion in 2024 and is projected to increase to $5.74 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%.
The Acute Kidney Injury Global Market is projected to reach a market size of $7.39 billion in 2029. This represents a compound annual growth rate (CAGR) of 6.5%.
Download Your Free Sample of the 2025 Acute Kidney Injury Market Report and Uncover Key Trends Now!The key drivers in the acute kidney injury market are:
• Rising prevalence of sepsis
• Growing demand for personalized treatment
• Increasing government healthcare initiatives
• High focus on personalized medicine and regenerative therapies.
The acute kidney injury market covered in this report is segmented –
1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury
2) By Treatment Type: Dialysis, Drug Therapy, Urinary Implants
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome
2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract
3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury
The key trends in the acute kidney injury market are:
• Wearable dialysis devices are emerging as a significant trend in the acute kidney injury market.
• The use of artificial intelligence for optimizing treatment is shaping the future of the market.
• Portable renal replacement therapy systems are becoming more commonplace.
• Advances in continuous renal replacement therapy (CRRT), remote monitoring, and telemedicine integration are also impactful emerging trends.
Major players in the acute kidney injury market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck & Co. Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis AG
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Medical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• B. Braun Melsungen AG
• Nipro Corporation
• Nikkiso Co. Ltd.
• Quark Pharmaceuticals Inc.
• Kringle Pharma Inc.
• Aptabio Therapeutics Inc.
• Alexion Pharmaceuticals Inc.
• Alloksys Life Sciences B.V.
• AM-Pharma B.V.
• Arch Biopartners Inc.
• Guard Therapeutics International AB
North America was the largest region in the acute kidney injury market in 2024